Carole Escartin, Emmanuel Brouillet. The Nrf2 pathway as a potential therapeutic target for Huntington disease. A commentary on “Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide
improve the behavioral phenotype and brain pathology in a transgenic mouse model
of Huntington disease”.
Free Radical Biology and Medicine, Elsevier, 2010, 49 (2), pp.144-146.
⟨10.1016/j.freeradbiomed.2010.04.009⟩.
⟨cea-02168439⟩ 
